黄芪中微量锌的测定

用分光光度法测定了黄芪中锌的含量,该法的平均回收率为99.01%.变异系数为1.50%.     

CdSe/ZnS-labeled carboxymethyl chitosan as a bioprobe for live cell imaging

A simple and convenient method for the construction of CdSe/ZnS-labeled polysaccharides as bioprobes were developed, which are highly biocompatible and photostable, and have been proven to be suitable for live cell imaging.     

容量法测定氧化钒中的各种价态钒

用NaOH溶液处理样品，分离V（V）然后以Fe(Ⅱ）滴定测定之。定量加入过量的V（V）到上述残渣中并用H2SO4溶解，用Fe(Ⅱ）滴定，计算出V（Ⅱ），V（Ⅲ）的含量。V（Ⅳ）的测定是通过从总钒量中扣除V（Ⅱ）、V（Ⅲ）、V（Ⅴ）的含量得到。V（Ⅱ）、V（Ⅲ）和V（Ⅴ）的回收率均大于96％，其8次测定结果的相对标准偏差分别为：9．8％、0．4％、1．2％；本法快速、简便，在实际应用中效果良好。     

非经典碳正离子问题

本文论述了非经典碳正离子这一问题的有关争论,是根据近期评论译述的。争论的中心是,全去甲莰正离子是在C—C或C—H键电子的σ-参与下形成非经典的离子,还是如Brown所指出的那样,是一个定域的经典离子,但受到立体的张力效应,从而加速了它在溶剂解中的形成。     

Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program

Summary In the preceding paper we reported on a docking study with the SYSDOC program for predicting the binding sites of huperzine A in acetylcholinesterase (AChE) [Pang, Y.-P. and Kozikowski, A.P., J. Comput.-Aided Mol. Design, 8 (1994) 669]. Here we present a prediction of the binding sites of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine (E2020) in AChE by the same method. E2020 is one of the most potent and selective reversible inhibitors of AChE, and this molecule has puzzled researchers, partly due to its flexible structure, in understanding how it binds to AChE. Based on the results of docking 1320 different conformers of E2020 into 69 different conformers of AChE and on the pharmacological data reported for E2020 and its analogs, we predict that both the R- and the S-isomer of E2020 span the whole binding cavity of AChE, with the ammonium group interacting mainly with Trp⁸⁴, Phe³³⁰ and Asp⁷², the phenyl group interacting mainly with Trp⁸⁴ and Phe³³⁰, and the indanone moiety interacting mainly with Tyr⁷⁰ and Trp²⁷⁹. The topography of the calculated E2020 binding sites provides insights into understanding the high potency of E2020 in the inhibition of AChE and provides hints as to possible structural modifications for identifying improved AChE inhibitors as potential therapeutics for the palliative treatment of Alzheimer's disease.